Área Sanitaria de Santiago de Compostela e Barbanza
Área sanitaria
Ospedale San Martino
Génova, ItaliaPublicacións en colaboración con investigadores/as de Ospedale San Martino (36)
2024
2023
-
CSF Findings in Relation to Clinical Characteristics, Subtype, and Disease Course in Patients With Guillain-Barré Syndrome
Neurology, Vol. 100, Núm. 23, pp. E2386-E2397
-
Criteria to evaluate efficacy of biologics in asthma: a Global Asthma Association survey
Expert Review of Respiratory Medicine, Vol. 17, Núm. 6, pp. 507-516
-
EANM position paper: theranostics in brain tumours—the present and the future
European Journal of Nuclear Medicine and Molecular Imaging
-
The NIA-AA revised clinical criteria for Alzheimer's disease: are they too advanced?
International Psychogeriatrics
2022
-
An International Perspective on Preceding Infections in Guillain-Barré Syndrome: The IGOS-1000 Cohort
Neurology, Vol. 99, Núm. 12, pp. E1299-E1313
-
Effect of Combination Antibiotic Empirical Therapy on Mortality in Neutropenic Cancer Patients with Pseudomonas aeruginosa Pneumonia
Microorganisms, Vol. 10, Núm. 4
-
Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia
New England Journal of Medicine, Vol. 386, Núm. 1, pp. 11-23
-
First international workshop of the ATM and cancer risk group (4-5 December 2019)
Familial Cancer, Vol. 21, Núm. 2, pp. 211-227
-
Predicting Outcome in Guillain-Barré Syndrome International Validation of the Modified Erasmus GBS Outcome Score
Neurology, Vol. 98, Núm. 5, pp. E518-E532
-
Pseudomonas aeruginosa Bloodstream Infections in Patients with Cancer: Differences between Patients with Hematological Malignancies and Solid Tumors
Pathogens, Vol. 11, Núm. 10
-
Real-Life Use of Ceftolozane/Tazobactam for the Treatment of Bloodstream Infection Due to Pseudomonas aeruginosa in Neutropenic Hematologic Patients: a Matched Control Study (ZENITH Study)
Microbiology Spectrum, Vol. 10, Núm. 3
2021
-
A 300 IR sublingual tablet is an effective, safe treatment for house dust mite–induced allergic rhinitis: An international, double-blind, placebo-controlled, randomized phase III clinical trial
Journal of Allergy and Clinical Immunology, Vol. 147, Núm. 3, pp. 1020-1030.e10
-
Impact of Bacillus Calmette-Gue´rin (BCG) vaccination on postoperative mortality in patients with perioperative SARS-CoV-2 infection
BJS Open
-
Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: The COVIDSurg mortality score
British Journal of Surgery, Vol. 19, Núm. 4
-
Personalized medicine for allergy treatment: Allergen immunotherapy still a unique and unmatched model
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 76, Núm. 4, pp. 1041-1052
2020
-
Clinical predictive model of multidrug resistance in neutropenic cancer patients with bloodstream infection due to Pseudomonas aeruginosa
Antimicrobial Agents and Chemotherapy, Vol. 64, Núm. 4
-
New Algorithms Improving PML Risk Stratification in MS Patients Treated With Natalizumab
Frontiers in Neurology, Vol. 11
2019
-
Erratum to: First line treatment of aplastic anemia with thymoglobuline in Europe and Asia: Outcome of 955 patients treated 2001-2012 (American Journal of Hematology, (2018), 93, 5, (643-648), 10.1002/ajh.25081)
American Journal of Hematology
-
Impact of antibiotic resistance on outcomes of neutropenic cancer patients with Pseudomonas aeruginosa bacteraemia (IRONIC study): Study protocol of a retrospective multicentre international study
BMJ Open, Vol. 9, Núm. 5